TCOYD® LIVE PLUS
New Immunotherapies and Stem Cell Research for Type 1s
TCOYD® LIVE PLUS events feature related content including videos, articles, and podcasts to learn even more on the topic!
TCOYD® LIVE PLUS
New Immunotherapies and Stem Cell Research for Type 1s
…With Expert Endocrinologists (Living well with T1D!) Steven V. Edelman, MD; and Jeremy Pettus, MD
Questions We Address Include:
• What are the causes of Type 1 diabetes?
• What are the 3 stages of T1D?
• How can the advances in immunotherapy prevent destruction of the pancreatic beta cells before the diagnosis?
• How do stem cells replace beta cell function in people who already have T1D?
• What does the future hold on curing or preventing T1D from ever occurring in the first place?
LEARN EVEN MORE WITH TCOYD® LIVE PLUS
– WATCH RELATED VIDEOS –
– READ RELATED ARTICLES –
“Promising Data on Vertex T1D Islet Cell Study, Still Recruiting”
READ ARTICLE
“FDA Approves Tzield to Prevent or Delay the Onset of Type 1 Diabetes”
READ ARTICLE
“The Benefits of Beta Cell Preservation in Type 1 Diabetes”
READ ARTICLE
– LISTEN TO RELATED PODCASTS –
– ACCESS YOUR DIABETES CARE –
–THIS TCOYD® LIVE PLUS IS BROUGHT TO YOU BY –
Sanofi is an innovative global healthcare company with one purpose: to chase the miracles of science to improve people’s lives. Sanofi wants to build a healthier, more resilient world, turning the impossible into the possible by discovering, developing, and delivering medicines and vaccines for millions of people around the world.
Provention Bio, a Sanofi company, envisions a world without autoimmune disease, unleashing the full potential of living without the burden of autoimmune disease.
Vertex creates new possibilities in medicine to cure diseases and improve people’s lives. We work with leading researchers, doctors, public health experts and other collaborators who share our vision for transforming the lives of people with serious diseases, their families and society.
